# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 1: Conditions


The participant’s legal representative has had an interview with the investigator, or another member of the investigating team, in which he has been given the opportunity to understand the objectives, risks and inconveniences of the trial and the conditions under which it is to be conducted.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/1/part/5/paragraph/1 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-1/part-5/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.